Dyer Timothy Mark → Addex Therapeutics Ltd. ADXN

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100

Passive Schedule 13G filer baseline
Short interest building (+205.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

5,613 shares short · +205.1% vs prior

Other 13D/G Filings on Addex Therapeutics Ltd.

Filed	Form	Filer	Stake	Shares
2026-09-04	SCHEDULE 13D/A	Dyer Timothy Mark	9.01%	19,165,714	view →
2026-08-27	SCHEDULE 13D/A	Dyer Timothy Mark	8.98%	19,095,510	view →
2023-04-05	SC	Dyer Timothy Mark	—	—	view →
2022-11-28	SC	Growth Equity Opportunities Fund IV, LLC	—	—	view →
2022-01-10	SC	Growth Equity Opportunities Fund IV, LLC	—	—	view →
2021-09-08	SC	Dyer Timothy Mark	—	—	view →

Other Filings by Dyer Timothy Mark

Filed	Form	Issuer	Stake	Shares
2026-09-04	SCHEDULE 13D/A	Addex Therapeutics Ltd.	9.01%	19,165,714	view →
2026-08-27	SCHEDULE 13D/A	Addex Therapeutics Ltd.	8.98%	19,095,510	view →
2023-04-05	SC	Addex Therapeutics Ltd. ADXN	—	—	view →
2021-09-08	SC	Addex Therapeutics Ltd. ADXN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →